↓ Skip to main content

Opiate Receptors and Antagonists

Overview of attention for book
Cover of 'Opiate Receptors and Antagonists'

Table of Contents

  1. Altmetric Badge
    Book Overview
  2. Altmetric Badge
    Chapter 1 Ultra-Low-Dose Opioid Antagonists Enhance Opioid Analgesia and Reduce Tolerance
  3. Altmetric Badge
    Chapter 2 Upregulation of Opioid Receptors
  4. Altmetric Badge
    Chapter 3 Imaging Human Brain Opioid Receptors: Applications to Substance Use Disorders
  5. Altmetric Badge
    Chapter 4 Opioid Receptor Antagonist-Mediated Signaling in the Immune System
  6. Altmetric Badge
    Chapter 5 The Chemistry and Pharmacology of μ-Opioid Antagonists
  7. Altmetric Badge
    Chapter 6 Medicinal Chemistry of Kappa Opioid Receptor Antagonists
  8. Altmetric Badge
    Chapter 7 The Chemistry and Pharmacology of Delta Opioid Antagonists
  9. Altmetric Badge
    Chapter 8 Novel Opioid Antagonists with Mixed/Dual Selectivity
  10. Altmetric Badge
    Chapter 9 Experimental Utility and Clinical Potential of Irreversible Opioid Antagonists
  11. Altmetric Badge
    Chapter 10 Methylnaltrexone: A Peripherally Acting Opioid Antagonist
  12. Altmetric Badge
    Chapter 11 Opioid Antagonist Effects in Animal Models Related to Opioid Abuse: Drug Discrimination and Drug Self-Administration
  13. Altmetric Badge
    Chapter 12 Naltrexone for Initiation and Maintenance of Opiate Abstinence
  14. Altmetric Badge
    Chapter 13 Ultra-Low-Dose Naltrexone Decreases Dependence and Addictive Properties of Opioids
  15. Altmetric Badge
    Chapter 14 Can a Combination Formulation Containing a Neutral Opiate Antagonist Decrease the Abuse of μ-Agonist Opiates
  16. Altmetric Badge
    Chapter 15 Effects of Opioid Antagonists on the Abuse-Related Effects of Psychomotor Stimulants and Nicotine
  17. Altmetric Badge
    Chapter 16 Potential Use of Opioid Antagonists in the Treatment of Marijuana Abuse and Dependence
  18. Altmetric Badge
    Chapter 17 Naltrexone in Smoking Cessation: A Review of the Literature and Future Directions
  19. Altmetric Badge
    Chapter 18 Opioid Antagonists and Ethanol's Ability to Reinforce Intake of Alcoholic Beverages: Preclinical Studies
  20. Altmetric Badge
    Chapter 19 Clinical Use of Opioid Antagonists in the Treatment of Alcohol Dependence
  21. Altmetric Badge
    Chapter 20 Preclinical Effects of Opioid Antagonists on Feeding and Appetite
  22. Altmetric Badge
    Chapter 21 CNS Opiate Systems and Eating Disorders
  23. Altmetric Badge
    Chapter 22 Potential Utility of Kappa Ligands in the Treatment of Mood Disorders
  24. Altmetric Badge
    Chapter 23 Opioid Antagonists in the Treatment of Pathological Gambling and Kleptomania
  25. Altmetric Badge
    Chapter 24 Efficacy of Opioid Antagonists in Attentuating Self-Injurious Behavior
  26. Altmetric Badge
    Chapter 25 Pharmacotherapeutic Effects of Opioid Antagonists in Alcohol-Abusing Patients with Schizophrenia
  27. Altmetric Badge
    Chapter 26 Current Issues in the Use of Opioid Antagonists (Naltrexone for Opiate Abuse: A Re-Educational Tool as Well as an Effective Drug)
  28. Altmetric Badge
    Chapter 27 Emergency Room Use of Opioid Antagonists in Drug Intoxication and Overdose
  29. Altmetric Badge
    Chapter 28 Kappa-Opioid Antagonists as Pruritogenic Agents
  30. Altmetric Badge
    Chapter 29 Clinical Effect of Opioid Antagonists on Clinical Pruritus
  31. Altmetric Badge
    Chapter 30 Effects of Opioid Antagonists on l-DOPA-Induced Dyskinesia in Parkinson's Disease
  32. Altmetric Badge
    Chapter 31 Endocrine Effects of Opioid Antagonists
  33. Altmetric Badge
    Chapter 32 Opioid Antagonists in Traumatic Shock: Animal and Human Studies
  34. Altmetric Badge
    Chapter 33 The Efficacy of Opioid Antagonists Against Heatstroke-Induced Ischemia and Injury in Rats
  35. Altmetric Badge
    Chapter 34 A Review of the Opioid System in Cancer Patients and Preliminary Results of Opioid Antagonists in the Treatment of Human Neoplasms
  36. Altmetric Badge
    Chapter 35 Nonclinical Pharmacology of VIVITROL®: A Monthly Injectable Naltrexone for the Treatment of Alcohol Dependence
  37. Altmetric Badge
    Chapter 36 The Development of Sustained-Release Naltrexone and Clinical Use in Treating Opiate Dependence
  38. Altmetric Badge
    Chapter 37 The Development of ProNeura Technology for the Treatment of Addictions
  39. Altmetric Badge
    Chapter 38 Development of Opioid Transdermal Delivery Systems
  40. Altmetric Badge
    Chapter 39 Intranasal Naloxone for Treatment of Opioid Overdose
Overall attention for this book and its chapters
Altmetric Badge

Mentioned by

4 tweeters
1 Wikipedia page


4 Dimensions

Readers on

6 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Opiate Receptors and Antagonists
Published by
Humana Press, January 2009
DOI 10.1007/978-1-59745-197-0
978-1-58829-881-2, 978-1-59745-197-0, 978-1-61737-822-5

Dean, Reginald L, Bilsky, Edward J, Negus, S. Stevens


Reginald Dean, Edward J. Bilsky, S. Stevens Negus

Twitter Demographics

The data shown below were collected from the profiles of 4 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 6 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 6 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 2 33%
Researcher 2 33%
Other 1 17%
Student > Bachelor 1 17%
Professor > Associate Professor 1 17%
Other 0 0%
Readers by discipline Count As %
Medicine and Dentistry 4 67%
Chemistry 1 17%
Agricultural and Biological Sciences 1 17%
Engineering 1 17%